|
GB335768A
(en)
|
1929-10-24 |
1930-10-02 |
Jacoviac Maurice |
Improvements in protecting devices for gramophone disc records
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
FI903489A0
(fi)
|
1988-11-11 |
1990-07-10 |
Medical Res Council |
Ligander med en enda sektion, receptorer innehaollande naemnda ligander, foerfaranden foer deras framstaellning samt anvaendning av liganderna och receptorerna.
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
ATE181571T1
(de)
|
1991-09-23 |
1999-07-15 |
Medical Res Council |
Methoden zur herstellung humanisierter antikörper
|
|
DE69334095T2
(de)
|
1992-07-17 |
2007-04-12 |
Dana-Farber Cancer Institute, Boston |
Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen
|
|
ATE427968T1
(de)
|
1992-08-21 |
2009-04-15 |
Univ Bruxelles |
Immunoglobuline ohne leichtkette
|
|
ATE204325T1
(de)
|
1993-04-29 |
2001-09-15 |
Unilever Nv |
Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae
|
|
DE69426527T2
(de)
|
1993-06-09 |
2001-08-30 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft |
Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen
|
|
FR2708622B1
(fr)
|
1993-08-02 |
1997-04-18 |
Raymond Hamers |
Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
|
|
US6091639A
(en)
|
1993-08-27 |
2000-07-18 |
Kabushiki Kaisha Toshiba |
Non-volatile semiconductor memory device and data programming method
|
|
DE69435112D1
(de)
|
1993-09-10 |
2008-08-21 |
Univ Columbia |
Verwendung von grünem fluoreszenzprotein
|
|
WO1995021191A1
(en)
|
1994-02-04 |
1995-08-10 |
William Ward |
Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
|
|
CA2183667A1
(en)
|
1994-02-22 |
1995-08-24 |
Wayne A. Marasco |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US5693492A
(en)
|
1995-05-05 |
1997-12-02 |
Merck & Co., Inc. |
DNA encoding glutamate gated chloride channels
|
|
ES2139329T3
(es)
|
1995-09-22 |
2000-02-01 |
Bioimage A S |
Nuevas variantes de la proteina fluorescente verde, gfp.
|
|
US6027881A
(en)
|
1996-05-08 |
2000-02-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
|
|
ATE374248T1
(de)
|
1996-06-27 |
2007-10-15 |
Vlaams Interuniv Inst Biotech |
Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
|
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
|
WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
|
EP1027073A2
(en)
|
1996-11-19 |
2000-08-16 |
Sangstat Medical Corporation |
Enhanced effects for hapten conjugated therapeutics
|
|
US6329516B1
(en)
|
1997-04-28 |
2001-12-11 |
Fmc Corporation |
Lepidopteran GABA-gated chloride channels
|
|
CN1203178C
(zh)
|
1997-10-27 |
2005-05-25 |
尤尼利弗公司 |
多价抗原结合蛋白
|
|
WO1999037681A2
(en)
|
1998-01-26 |
1999-07-29 |
Unilever Plc |
Method for producing antibody fragments
|
|
EP1469883A2
(en)
|
1998-02-19 |
2004-10-27 |
Xcyte Therapies, Inc. |
Compositions and methods for regulating lymphocyte activation
|
|
EP0967284A1
(en)
|
1998-05-28 |
1999-12-29 |
Pfizer Limited |
Phosphodiesterases
|
|
GB9824632D0
(en)
|
1998-11-10 |
1999-01-06 |
Celltech Therapeutics Ltd |
Biological compounds
|
|
BR9916765A
(pt)
|
1999-01-05 |
2001-09-25 |
Unilever Nv |
Processo para produzir um material imunoadsorvente, uso de uma proteìna que é ligada por meio de uma ligação covalente a um fragmento de anticorpo, material imunadsorvente, uso de um material, e, kit de teste diagnóstico
|
|
EP1144616B2
(en)
|
1999-01-19 |
2009-01-14 |
Unilever Plc |
Method for producing antibody fragments
|
|
WO2000046383A2
(en)
|
1999-02-05 |
2000-08-10 |
Rijksuniversiteit Leiden |
Method of modulating metabolite biosynthesis in recombinant cells
|
|
CA2367955C
(en)
|
1999-03-15 |
2009-05-19 |
University Of British Columbia |
Abc1 polypeptide and methods and reagents for modulating cholesterol levels
|
|
WO2000065057A1
(en)
|
1999-04-22 |
2000-11-02 |
Unilever Plc |
Inhibition of viral infection using monovalent antigen-binding proteins
|
|
TR200200441T2
(tr)
|
1999-06-18 |
2002-11-21 |
Cv Therapeutics, Inc. |
ATP bağlayıcı kaset transportör protein ABC1' i kullanarak kolesterolün dışa akımını artırmak ve HDL' yi yükseltmek için terkipler ve yöntemler.
|
|
AU6322900A
(en)
|
1999-08-02 |
2001-02-19 |
Keygene N.V. |
Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method
|
|
GB9922124D0
(en)
|
1999-09-17 |
1999-11-17 |
Pfizer Ltd |
Phosphodiesterase enzymes
|
|
US6479280B1
(en)
|
1999-09-24 |
2002-11-12 |
Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw |
Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
|
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
|
DE19955408A1
(de)
|
1999-11-18 |
2001-05-23 |
Bayer Ag |
GABA-B-Rezeptoren
|
|
WO2001044301A1
(en)
|
1999-11-29 |
2001-06-21 |
Unilever Plc |
Immobilized single domain antigen-binding molecules
|
|
ES2275563T3
(es)
|
1999-11-29 |
2007-06-16 |
Unilever N.V. |
Inmovilizacion de proteinas mediante el uso de un segmento polipeptidico.
|
|
CA2921260A1
(en)
|
1999-12-24 |
2001-06-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
ES2324280T3
(es)
|
2000-03-14 |
2009-08-04 |
Unilever N.V. |
Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
|
|
CA2380443C
(en)
|
2000-05-26 |
2013-03-12 |
Ginette Dubuc |
Single-domain antigen-binding antibody fragments derived from llama antibodies
|
|
US6741957B1
(en)
|
2000-07-21 |
2004-05-25 |
Daimlerchrysler Corporation |
Analytical tire model for vehicle durability and ride comfort analysis
|
|
ATE513854T1
(de)
|
2000-12-13 |
2011-07-15 |
Bac Ip B V |
Proteinraster aus variablen domänen der schweren immunoglobulinkette von kamelen
|
|
US7054297B1
(en)
|
2000-12-28 |
2006-05-30 |
Cisco Technology, Inc. |
Distribution of packets to high data rate communications devices using multicast protocols
|
|
CN1911965B
(zh)
|
2001-01-17 |
2013-05-29 |
新兴产品开发西雅图有限公司 |
结合域-免疫球蛋白融合蛋白
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US20060073141A1
(en)
|
2001-06-28 |
2006-04-06 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
CA2447851C
(en)
|
2001-06-28 |
2012-08-28 |
Domantis Limited |
Dual-specific ligand and its use
|
|
JP2004538324A
(ja)
|
2001-08-03 |
2004-12-24 |
メディカル リサーチ カウンシル |
細胞内抗体
|
|
WO2003025020A1
(en)
|
2001-09-13 |
2003-03-27 |
Institute For Antibodies Co., Ltd. |
Method of constructing camel antibody library
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
KR100599789B1
(ko)
|
2001-12-03 |
2006-07-12 |
삼성에스디아이 주식회사 |
방열효율이 향상된 플라즈마 디스플레이 장치 및 그 제조방법
|
|
US20050214857A1
(en)
|
2001-12-11 |
2005-09-29 |
Algonomics N.V. |
Method for displaying loops from immunoglobulin domains in different contexts
|
|
WO2003054016A2
(en)
|
2001-12-21 |
2003-07-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Method for cloning of variable domain sequences
|
|
WO2003055527A2
(en)
|
2002-01-03 |
2003-07-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Immunoconjugates useful for treatment of tumours
|
|
DK1517921T3
(da)
|
2002-06-28 |
2006-10-09 |
Domantis Ltd |
Immunglobulin-enkeltvariable antigen-bindende domæner og dobbeltspecifikke konstruktioner deraf
|
|
US7004940B2
(en)
|
2002-10-10 |
2006-02-28 |
Ethicon, Inc. |
Devices for performing thermal ablation having movable ultrasound transducers
|
|
WO2004037999A2
(en)
|
2002-10-23 |
2004-05-06 |
Ludwig Institute For Cancer Research |
A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
|
|
EP3299393A1
(en)
|
2002-11-08 |
2018-03-28 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
AU2003286002B2
(en)
|
2002-11-08 |
2011-06-16 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
GB0230203D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
|
US7432330B2
(en)
|
2002-12-31 |
2008-10-07 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
CA2512545C
(en)
|
2003-01-10 |
2015-06-30 |
Karen Silence |
Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf)
|
|
US7461263B2
(en)
|
2003-01-23 |
2008-12-02 |
Unspam, Llc. |
Method and apparatus for a non-revealing do-not-contact list system
|
|
AU2004220325B2
(en)
|
2003-06-30 |
2011-05-12 |
Domantis Limited |
Polypeptides
|
|
AU2003264053A1
(en)
|
2003-08-12 |
2005-03-10 |
William M. Yarbrough |
Treatment for acne vulgaris and method of use
|
|
DE60334645D1
(de)
|
2003-11-07 |
2010-12-02 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
|
US7207410B2
(en)
|
2004-04-29 |
2007-04-24 |
Daimlerchrysler Corporation |
Apparatus and method for enhanced impact sensing
|
|
US7180370B2
(en)
|
2004-09-01 |
2007-02-20 |
Micron Technology, Inc. |
CMOS amplifiers with frequency compensating capacitors
|
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
|
WO2006040153A2
(en)
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
|
JP2008528010A
(ja)
|
2005-01-31 |
2008-07-31 |
アブリンクス ナームローゼ フェンノートシャップ |
重鎖抗体の可変ドメイン配列を作出する方法
|
|
CN103254309B
(zh)
|
2005-05-18 |
2017-09-26 |
埃博灵克斯股份有限公司 |
针对肿瘤坏死因子α的改进的纳米体TM
|
|
RU2433139C2
(ru)
|
2005-05-20 |
2011-11-10 |
Аблинкс Н.В. |
Nanobodies tm для лечения заболеваний, опосредованных агрегацией
|
|
JP2010500876A
(ja)
|
2006-08-18 |
2010-01-14 |
アブリンクス エン．ヴェー． |
Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド
|
|
JP2010502208A
(ja)
|
2006-09-08 |
2010-01-28 |
アブリンクス エン．ヴェー． |
半減期の長い血清アルブミン結合タンパク質
|
|
US20100034194A1
(en)
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
|
ATE536369T1
(de)
|
2006-10-11 |
2011-12-15 |
Ablynx Nv |
Im wesentlichen ph-wert-unabhängigerweise an serumproteine bindende aminosäuresequenzen, verbindungen, die diese enthalten, und deren verwendung
|
|
CA2671581A1
(en)
|
2006-12-05 |
2008-06-12 |
Ablynx N.V. |
Peptides capable of binding to serum proteins
|
|
US20110118185A9
(en)
|
2007-02-21 |
2011-05-19 |
Ablynx N.V. |
Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
|
|
EP2152747B1
(en)
|
2007-05-24 |
2018-01-03 |
Ablynx N.V. |
Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
|
|
MX2010005783A
(es)
|
2007-11-27 |
2010-08-10 |
Ablynx Nv |
Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
|
|
KR101470690B1
(ko)
|
2009-04-10 |
2014-12-10 |
아블린쓰 엔.브이. |
Ｉｌ－６ｒ에 대한 개선된 아미노산 서열 및 ｉｌ－６ｒ 관련 질환 및 질병의 치료를 위한 그를 포함하는 폴리펩티드
|
|
CN102180950B
(zh)
*
|
2011-02-24 |
2013-06-05 |
华中科技大学同济医学院附属协和医院 |
一种人源性电压门控钾通道1.3免疫原性肽段及其用途
|
|
SG194982A1
(en)
|
2011-06-23 |
2013-12-30 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
CN106046168A
(zh)
|
2011-06-23 |
2016-10-26 |
埃博灵克斯股份有限公司 |
结合血清白蛋白的蛋白
|
|
NL2013661B1
(en)
*
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|